News
Health and Me on MSN47m
Could This New Alzheimer’s Drug Buy Patients Four More Good Years? Here Is What We KnowA new Alzheimer’s drug, lecanemab, may slow disease progression and offer patients up to four extra years of stable health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback